(Press-News.org) The biology underpinning a rare genetic mutation that allows its carrier to live virtually pain-free, heal more rapidly and experience reduced anxiety and fear, has been uncovered by new research from UCL.
The study, published in Brain, follows up the team’s discovery in 2019 of the FAAH-OUT gene and the rare mutations that cause Jo Cameron to feel virtually no pain and never feel anxious or afraid. The new research describes how the mutation in FAAH-OUT ‘turns down’ FAAH gene expression, as well as the knock-on effects on other molecular pathways linked to wound healing and mood. It is hoped the findings will lead to new drug targets and open up new avenues of research in these areas.
Jo, who lives in Scotland, was first referred to pain geneticists at UCL in 2013, after her doctor noticed that she experienced no pain after major surgeries on her hip and hand. After six years of searching, they identified a new gene that they named FAAH-OUT, which contained a rare genetic mutation. In combination with another, more common mutation in FAAH, it was found to be the cause of Jo’s unique characteristics.
The area of the genome containing FAAH-OUT had previously been assumed to be ‘junk’ DNA1 that had no function, but it was found to mediate the expression of FAAH, a gene that is part of the endocannabinoid system and that is well-known for its involvement in pain, mood and memory.
In this study, the team from UCL sought to understand how FAAH-OUT works at a molecular level, the first step towards being able to take advantage of this unique biology for applications like drug discovery.
This included a range of approaches, such as CRISPR-Cas9 experiments on cell lines to mimic the effect of the mutation on other genes, as well as analysing the expression of genes to see which were active in molecular pathways involved with pain, mood and healing.
The team observed that FAAH-OUT regulates the expression of FAAH. When it is significantly turned down as a result of the mutation carried by Jo Cameron, FAAH enzyme activity levels are significantly reduced.
Dr Andrei Okorokov (UCL Medicine), a senior author of the study, said: “The FAAH-OUT gene is just one small corner of a vast continent, which this study has begun to map. As well as the molecular basis for painlessness, these explorations have identified molecular pathways affecting wound healing and mood, all influenced by the FAAH-OUT mutation. As scientists it is our duty to explore and I think these findings will have important implications for areas of research such as wound healing, depression and more.”
The authors looked at fibroblasts taken from patients to study the effects of the FAAH-OUT-FAAH axis on other molecular pathways. While the mutations that Jo Cameron carries turn down FAAH, they also found a further 797 genes that were turned up and 348 that were turned down. This included alterations to the WNT pathway that is associated with wound healing, with increased activity in the WNT16 gene that has been previously linked to bone regeneration.
Two other key genes that were altered were BDNF, which has previously been linked to mood regulation and ACKR3, which helps to regulate opioid levels. These gene changes may contribute to Jo Cameron’s low anxiety, fear and pain.
Professor James Cox (UCL Medicine), a senior author of the study, said: “The initial discovery of the genetic root of Jo Cameron’s unique phenotype was a eureka moment and hugely exciting, but these current findings are where things really start to get interesting. By understanding precisely what is happening at a molecular level, we can start to understand the biology involved and that opens up possibilities for drug discovery that could one day have far-reaching positive impacts for patients.”
This research was supported by the Medical Research Council (MRC) and Wellcome.
1 So called ‘junk’ DNA describes regions of the genome or non-coding genes that don’t create proteins. They were once thought redundant, but in recent years researchers have begun to discover the role of ‘dark’ regions of the genome in regulating coding genes.
Study reveals unique molecular machinery of woman who can’t feel pain
ELSE PRESS RELEASES FROM THIS DATE:
NTT and OIST make the first simultaneous atmospheric and marine observations directly beneath a violent, Category 5 typhoon in the North-West Pacific
Joint Press Release Nippon Telegraph and Telephone Corporation (NTT, Head Office: Chiyoda-ku, Tokyo; President & CEO: Akira Shimada) and the Okinawa Institute of Science and Technology (OIST, Head office: Onna-son, Kunigami-gun, Okinawa, Japan, Acting President: Dr. Albrecht Wagner) have successfully conducted the world’s first simultaneous marine and atmospheric measurements at multiple locations directly beneath a violent, Category 5*1, which is the strongest class, typhoon in the North-West Pacific, before it reached land. These observations were made directly beneath typhoon No. 11, called “Hinnamnor”/”Henry”, ...
Study finds school improvement plan (SIP) templates continue to be enacted out of compliance rather than as mechanism for spurring and sustaining improvement efforts in schools
School accountability policies from around the world list an array of mandates and recommendations to improve schools. One prevalent mandate, especially in the United States, calls for the development of a school improvement plan (SIP). Since the 1970s, many U.S. states have required that schools develop SIPs, and, in the 1990s, the U.S. federal government started to require that all state-designated underperforming schools develop SIPs (IASA, 1994; Odden & Dougherty, 1982). These school accountability policy mandates assert that SIPs are an improvement tool for educators to use to set direction, ...
Mays Cancer Center conducts only clinical trial in America of a specific drug combination for lethal brain cancer glioblastoma
SAN ANTONIO (May 23, 2023) — The Mays Cancer Center at The University of Texas Health Science Center at San Antonio recently conducted a clinical trial combining two drugs in patients with recurrent, high-grade glioblastoma (GBM). The Mays Cancer Center, one of the four National Cancer Institute-Designated Cancer Centers in Texas, is the only center in America to conduct this trial. Andrew Brenner, MD, PhD, professor of medicine at the UT Health Science Center San Antonio and a specialist in both breast cancer and malignancies of the brain and spinal cord, initiated the clinical trial. “Glioblastoma ...
Researchers use nuclear spins neighboring a lanthanide atom in a crystal to create Greenberger-Horne-Zeilinger quantum states
Researchers have experimentally demonstrated a new quantum information storage protocol that can be used to create Greenberger-Horne-Zeilinger (GHZ) quantum states. There is a great deal of interest in these complex entangled states because of their potential use in quantum sensing and quantum error correction applications. Chun-Ju Wu from the California Institute of Technology will present this research at the Optica Quantum 2.0 Conference and Exhibition, as a hybrid event 18-22 June in Denver, Colorado. Quantum-based technologies store information ...
Recent papers in ACS Engineering Au
ACS Engineering Au is a member of the ACS Au family of journals. These publications are open access, and each one focuses on a specific field relevant to chemistry. Here, we take a look at a few recent papers from ACS Engineering Au, which publishes a broad scope of research from both academic and industrial settings. The journal welcomes papers on topics such as process design, product research, energy and fuels, and measurement techniques. Reporters can request free access to these papers by emailing firstname.lastname@example.org. "Heat ...
Biomarkers may help ID treatment of acute kidney injury
Hospital inpatients who develop an acute kidney injury (AKI) generally fare poorly after being discharged, and have few options for effective treatment. A UW Medicine-led study published recently in American Journal of Kidney Diseases suggests that new tests might improve this narrative. In the study, “about 30% of the patients that came into the hospital developed AKI, which means in a matter of hours or days, their kidneys might be failing because of reaction to drugs or contracting sepsis,” said lead author Dr. Pavan Bhatraju, an assistant professor of pulmonary and critical care medicine at the University of Washington School of Medicine. Causes ...
nTIDE May 2023 Deeper Dive: How did COVID-19 lockdown impact employment of individuals with visual disabilities?
East Hanover, NJ – May 23, 2023 – New data show that while individuals with visual disabilities were slow to recover employment because of the effects of the COVID-2019 lockdown, they have made headway, depending on their level of disability, almost meeting their pre-pandemic levels. Possible reasons for their slower recovery include major safety concerns due to the shortage of personal protective equipment, less access to vaccines, and their vulnerability to severe consequences of COVID, according to experts speaking during last Friday’s nTIDE Deeper Dive Lunch & Learn Webinar. Using data from the U.S. Bureau of Labor Statistics (BLS) for persons ages 16-64, the ...
Few adult smokers and nonsmokers think e-cigarettes have lower levels of harmful chemicals than cigarettes
About half of cigarette smokers and young adult non-smokers think that nicotine-based electronic cigarettes have the same amount or even more harmful chemicals than regular tobacco-based cigarettes, according to a Rutgers study. The study, published in Addiction, measured perceived levels of harmful chemicals in e-cigarettes compared with cigarettes using national samples of more than 1,000 adults ages 18 and older who smoke cigarettes and 1,000-plus adults ages 18 to 29 who are nonsmokers. The study also measured associations with e-cigarette/cigarette relative harm perceptions, e-cigarette use and interest. About 20 percent of all participants ...
Capturing transporter structure paves the way for drug development
(Memphis, Tenn.—May 23, 2023) Scientists at St. Jude Children’s Research Hospital and the University of Texas Southwestern Medical Center studied the structure and function of a transporter involved in cancer and immunity. They captured six structures of the transporter, including when it was bound to an inhibitor, providing unprecedented insight into how it works. The findings, published in Cell, have implications for drug development. Transporters escort substances across the cell membrane so that they can carry out their functions. Sphingosine-1-phosphate (S1P) is an important signaling molecule that regulates the immune system, blood vessel formation, auditory ...
Did dome-headed dinosaurs sport bristly headgear?
If you look at enough dinosaur fossils, you'll see that their skulls sport an amazing variety of bony ornaments, ranging from the horns of Triceratops and the mohawk-like crests of hadrosaurs to the bumps and knobs covering the head of Tyrannosaurus rex. But paleontologists are increasingly finding evidence that dinosaurs had even more elaborate head ornaments not preserved with the fossil skulls — structures made of keratin, the stuff of fingernails, that were likely used as visual signals or semaphores to others of their kind. A newly described species of dome-headed dinosaur — a pachycephalosaur ...